ID

31734

Beschreibung

The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00718952

Link

https://clinicaltrials.gov/show/NCT00718952

Stichworte

Versionen (1)
  1. 24.09.18 24.09.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

24. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Pulmonary Hypertension NCT00718952

Englisch

Eligibility Pulmonary Hypertension NCT00718952

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects aged 12-65.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
confirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with eisenmenger syndrome) associated pulmonary hypertension.
Beschreibung

Idiopathic pulmonary hypertension | Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Eisenmenger Complex

Datentyp

boolean

Alias
UMLS CUI [1]
C0152171
UMLS CUI [2]
C3697982
UMLS CUI [3]
C3697119
UMLS CUI [4]
C0013743
baseline 6-minutes walking distance 150m-550m.
Beschreibung

6-Minute Walk Test Meter Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0430515
UMLS CUI [1,2]
C0475209
UMLS CUI [1,3]
C1265611
who pulmonary hypertension function ii-iii with non-responder to calcium channel blockers.
Beschreibung

Pulmonary Hypertension WHO classification | Therapy non-responder Calcium Channel Blockers

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C4267671
UMLS CUI [2,1]
C0919875
UMLS CUI [2,2]
C0006684
documented written informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
the other types of pulmonary hypertension.
Beschreibung

Pulmonary Hypertension Type Other

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C0205394
subjects who refuse to subscribe written informed consents or can't cooperate with the trial well.
Beschreibung

Informed Consent Refused | Protocol Compliance Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0439801
subjects with serious acute or chronic disease involved liver, kidney, and brain or have to use potent cyp3a4-inhibitor or nitrate to treat the underlying diseases.
Beschreibung

Disease Serious Involvement Liver | Disease Serious Involvement Kidney | Disease Serious Involvement Brain | Chronic disease Serious Involvement Liver | Chronic disease Serious Involvement Kidney | Chronic disease Serious Involvement Brain | CYP3A4 Inhibitor Primary disorders | Nitrate Primary disorders

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0023884
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C1314939
UMLS CUI [2,4]
C0022646
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0006104
UMLS CUI [4,1]
C0008679
UMLS CUI [4,2]
C0205404
UMLS CUI [4,3]
C1314939
UMLS CUI [4,4]
C0023884
UMLS CUI [5,1]
C0008679
UMLS CUI [5,2]
C0205404
UMLS CUI [5,3]
C1314939
UMLS CUI [5,4]
C0022646
UMLS CUI [6,1]
C0008679
UMLS CUI [6,2]
C0205404
UMLS CUI [6,3]
C1314939
UMLS CUI [6,4]
C0006104
UMLS CUI [7,1]
C3830624
UMLS CUI [7,2]
C0277554
UMLS CUI [8,1]
C0028125
UMLS CUI [8,2]
C0277554
subjects who are currently treated with sildenafil for pah or taking sildenafil or tadalafil.
Beschreibung

Sildenafil Pulmonary arterial hypertension | sildenafil | tadalafil

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0529793
UMLS CUI [1,2]
C2973725
UMLS CUI [2]
C0529793
UMLS CUI [3]
C1176316
other contraindications in package insert.
Beschreibung

Package Insert Containing Medical contraindications

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030174
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C1301624
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Pulmonary Hypertension NCT00718952

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
subjects aged 12-65.
boolean
C0001779 (UMLS CUI [1])
Idiopathic pulmonary hypertension | Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Eisenmenger Complex
Item
confirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with eisenmenger syndrome) associated pulmonary hypertension.
boolean
C0152171 (UMLS CUI [1])
C3697982 (UMLS CUI [2])
C3697119 (UMLS CUI [3])
C0013743 (UMLS CUI [4])
6-Minute Walk Test Meter Quantity
Item
baseline 6-minutes walking distance 150m-550m.
boolean
C0430515 (UMLS CUI [1,1])
C0475209 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Pulmonary Hypertension WHO classification | Therapy non-responder Calcium Channel Blockers
Item
who pulmonary hypertension function ii-iii with non-responder to calcium channel blockers.
boolean
C0020542 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C0006684 (UMLS CUI [2,2])
Informed Consent
Item
documented written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pulmonary Hypertension Type Other
Item
the other types of pulmonary hypertension.
boolean
C0020542 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Informed Consent Refused | Protocol Compliance Limited
Item
subjects who refuse to subscribe written informed consents or can't cooperate with the trial well.
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Disease Serious Involvement Liver | Disease Serious Involvement Kidney | Disease Serious Involvement Brain | Chronic disease Serious Involvement Liver | Chronic disease Serious Involvement Kidney | Chronic disease Serious Involvement Brain | CYP3A4 Inhibitor Primary disorders | Nitrate Primary disorders
Item
subjects with serious acute or chronic disease involved liver, kidney, and brain or have to use potent cyp3a4-inhibitor or nitrate to treat the underlying diseases.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0023884 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
C0022646 (UMLS CUI [2,4])
C0012634 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0006104 (UMLS CUI [3,4])
C0008679 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C0023884 (UMLS CUI [4,4])
C0008679 (UMLS CUI [5,1])
C0205404 (UMLS CUI [5,2])
C1314939 (UMLS CUI [5,3])
C0022646 (UMLS CUI [5,4])
C0008679 (UMLS CUI [6,1])
C0205404 (UMLS CUI [6,2])
C1314939 (UMLS CUI [6,3])
C0006104 (UMLS CUI [6,4])
C3830624 (UMLS CUI [7,1])
C0277554 (UMLS CUI [7,2])
C0028125 (UMLS CUI [8,1])
C0277554 (UMLS CUI [8,2])
Sildenafil Pulmonary arterial hypertension | sildenafil | tadalafil
Item
subjects who are currently treated with sildenafil for pah or taking sildenafil or tadalafil.
boolean
C0529793 (UMLS CUI [1,1])
C2973725 (UMLS CUI [1,2])
C0529793 (UMLS CUI [2])
C1176316 (UMLS CUI [3])
Package Insert Containing Medical contraindications
Item
other contraindications in package insert.
boolean
C0030174 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video